News | RIVM

Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination

Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.

Slightly fewer adult smokers

In 2018, 22.4 per cent of the Dutch adult population indicated they were occasional smokers.

Vaccination against meningococcal disease starts for teens aged 14 to 18

This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.

Vaccination schedule for babies reviewed after introduction whooping cough vaccination for pregnant women

Whooping cough is a dangerous disease for new born, unvaccinated babies. Starting at the end of 2019, the whooping cough vaccination will be offered nationwide to pregnant women.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Teen vaccination against meningococcal disease starts

From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.

New method for toxicological assessment of perfluoro mixtures

Perfluoro (PFAS) is a group of substances that contains PFOS, PFOA and GenX. Perfluoro substances often occur as pollution in ground water and drinking water.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

Proposal for water quality standards for PFOA

RIVM proposes water quality standards for perfluoro octanoic acid (PFOA). PFOA is a man-made chemical that is used to protect surfaces.